DONGSUN GPHARMACEUTICAL financial statements, including revenue, expenses, profit, and loss

The total revenue of 002210 for the last quarter is 21.44 B KRW, and it's 1.39% lower compared to the previous quarter. The net income of Q3 24 is -1.46 B KRW.